tirzepatide heart disease and Cardiovascular Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Failure Management Semaglutide may reduce heart events

H+, Hydrogen ions

About this article Once-Weekly Semaglutide in Adults with Overweight or Obesity The New England Journal of Medicine (NEJM) (Mar 2021) Clinical Recommendations for the Management of Adverse Events Associated with Glucagon-Like Peptide-1 Receptor Agonists Journal of Clinical Medicine (Dec 2022) Notes:Article published

Because GLP-1 drugs also have an effect on inflammation and the immune system, combining them with biologics could create a heightened risk of infection or immune-related issues

[1] We cover the molecules biology in more depth in our reference on what tesamorelin is, how it works, and its studied effects

This type of inflammation can simmer away silently for decades, which is why its such a problem for issues like arthritis